Protagonist Therapeutics Inc (NASDAQ:PTGX)
| 17.30 BATS BZX Real-Time Price As of 3:08pm ET |  +1.84 / +11.90%Today’s Change | 12.80 Today|||52-Week Range 50.54 | -14.19% Year-to-Date |
Latest PTGX News | Press Releases
| Protagonist Therapeutics (PTGX) Moves 18.2% Higher: Will This Strength Last? Sep 22 / Zacks.com - Paid Partner Content | Why Protagonist Therapeutics Stock Is Tanking Today Sep 17 / MotleyFool.com - Paid Partner Content |
| Why Protagonist Therapeutics Stock Plunged Today Sep 20 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 15.46 |
| Today’s open | 15.62 |
| Day’s range | 15.51 - 17.35 |
| Volume | 113,184 |
| Average volume (3 months) | 792,821 |
| Market cap | $828.8M |
Data as of 3:08pm ET, 09/23/2021
Growth & Valuation
| Earnings growth (last year) | +35.48% |
| Earnings growth (this year) | -31.32% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +12,293.07% |
| P/E ratio | NM |
| Price/Sales | 24.22 |
| Price/Book | 2.73 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRISCuris Inc | +0.06 | +0.79% |
| DTILPrecision BioScience... | +0.49 | +3.84% |
| ANABAnaptysBio Inc | -0.19 | -0.67% |
| MRSNMersana Therapeutics... | +0.09 | +0.94% |
Data as of 3:08pm ET, 09/23/2021
Financials
| Next reporting date | November 10, 2021 |
| EPS forecast (this quarter) | -$0.67 |
| Annual revenue (last year) | $28.6M |
| Annual profit (last year) | -$66.2M |
| Net profit margin | -231.07% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newark, California |
Forecasts
